Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 9 NETWORK 7 NIH 4 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 472 Brain Neoplasms 306 Glioma 257 Neoplasms 122 Astrocytoma 88 Carcinoma, Non-Small-Cell Lung 76 Breast Neoplasms 70 Neuroblastoma 65 Central Nervous System Neoplasms 61 Melanoma 58 Recurrence 46 Lung Neoplasms 45 Pancreatic Neoplasms 41 Oligodendroglioma 37 Ovarian Neoplasms 36 Colorectal Neoplasms 36 Neoplasm Metastasis 33 Sarcoma 32 Medulloblastoma 28 Stomach Neoplasms 27 Gliosarcoma 27 Lymphoma 25 Prostatic Neoplasms 24 Head and Neck Neoplasms 24 Neurofibromatosis 1 23 Rhabdomyosarcoma 21 Neurofibroma, Plexiform 19 Esophageal Neoplasms 19 Diffuse Intrinsic Pontine Glioma 19 Cholangiocarcinoma 19

Interventions

fludarabine 1 Influenza Vaccines 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Ganglioneuroblastoma × CNS × Clear all

NCT07502287 2026-03-30

DUAL-NK-NB

Beijing Biotech

Phase 1/2 Recruiting

Neuroblastoma, Recurrence, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡